Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Qiagen's Clinical Interpretation Tools; Station X's GenePool Reference; More

Premium

Qiagen has announced the impending launches of clinical interpretation tools CLC Cancer Research Workbench and Ingenuity Clinical. CLC Cancer Research Workbench will launch in April 2014 and is a cancer-specific analysis workflow that interprets next-gen sequencing data. Ingenuity Clinical is being used by 20 clinical testing laboratories in early access and will launch commercially later this year. The solution does automated scoring, interpretation, and reporting of findings in standardized, HIPPA-compliant formats.


Station X has launched GenePool Reference, software for the management, sharing, and analysis of population-scale genomic data. The firm has made available all of the gene expression data from the Cancer Genome Atlas, which includes RNA-seq data covering 25 cancer types. In total, GenePool Reference currently contains over 7,000 samples of DNA and RNA sequence data.


Connective Tissue Gene Tests has added deletion and duplication testing to 12 of its Sanger sequencing tests to diagnose genetic forms of connective tissue disorders. The company offers a total of 33 Sanger-based tests and nine next-gen sequencing-based gene panels.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.